
Mineralys Therapeutics Inc (MLYS)
NASDAQ
Fin d'année 31 Décembre 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -461.104 | -307.795 | -47.463 | -39.28 | -77.725 |
Return on Equity (%) | 190.492 | 146.354 | 79.259 | -76.129 | -82.241 |
Return on Invested Capital (%) | 162.732 | -1527.948 | -56.815 | -49.31 | -89.619 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.062 | 0.103 | 0.464 | 5.867 | 3.843 |
Earnings Per Share | -0.059 | -0.33 | -0.13 | -1.749 | -3.573 |
Cash Per Share | 0.024 | 0.181 | 0.383 | 1.199 | 2.292 |
Working Capital Per Share | -0.062 | 0.103 | 0.457 | 5.805 | 3.832 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.059 | -0.33 | -0.13 | -1.749 | -3.573 |
EBITDA Per Share | -0.059 | -0.33 | -0.13 | -1.749 | -3.573 |
Free Cash Flow Per Share | -0.059 | -0.33 | -0.13 | -1.749 | -3.572 |
Fin d'année 31 Décembre 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 58,44M | 58,76M | 6,42M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 607,5M |
Ratio cours/bénéfice | -3,76 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 5,87 |
Ratio prix/valeur comptable | 3,5 |
Rendement de dividende | - |
Actions en circulation | 49,84M |
Volume moyen (1 semaine) | 1,58M |
Volume moyen (1 mois) | 1,45M |
Variation sur 52 semaines | 4,02% |
Plus haut sur 52 semaines | 18,38 |
Plus bas sur 52 semaines | 8,241 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales